Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02696603 · ClinicalTrials.gov registry record · NA

Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)

A NA study of Parkinson Disease and Movement Disorders, sponsored by Sage Bionetworks.

Active
Registry status
NA
Development phase
20,000
Enrollment target
1
Study location

NCT02696603: Active NA study of Parkinson Disease and Movement Disorders, sponsored by Sage Bionetworks.

NCT02696603 is a NA study of Parkinson Disease and Movement Disorders that is active but no longer recruiting, run by Sage Bionetworks. The registered enrollment target is 20,000 participants, above the 5,259-participant average among 297 other Parkinson Disease trials with a reported enrollment target (280% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02696603, a NA study of Parkinson Disease and Movement Disorders, is active but no longer recruiting, sponsored by Sage Bionetworks.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20,000 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to understand variation in the symptoms of Parkinson disease. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

Primary Outcome

Results of participant self-assessment surveys will be analyzed using descriptive statistics. These results may also be compared with other intervention results.

Interventions

  • BEHAVIORAL Participant self-assessment surveys
  • BEHAVIORAL Phonation
  • BEHAVIORAL Gait and balance
  • BEHAVIORAL Memory
  • BEHAVIORAL Dexterity

Study Locations (1)

Washington

  • Sage Bionetworks - Seattle

Trial Details

FieldValue
Enrollment Target 20,000 participants
Start Date 2015-03
Est. Completion 2025-12-31
Phase NA
Sage Bionetworks

2 total trials

What the registry record for NCT02696603 still lists

NCT02696603 is an interventional study that assigns participants to a tested intervention. Its 20,000 participants enrollment target places it among the larger protocols in the corpus, above the 5,259-participant average among 297 other Parkinson Disease trials with a reported enrollment target (280% higher).

The record links to 7 conditions, with Parkinson Disease appearing as the primary indexed condition, and to 5 interventions - of which Participant self-assessment surveys is the first listed.

NCT02696603 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT02696603 about?

NCT02696603 is a clinical study titled "Mobile Parkinson Observatory for Worldwide, Evidence-based Research (mPower)". The purpose of this study is to understand variation in the symptoms of Parkinson disease. This study uses an iPhone app to record these symptoms through questionnaires and sensors.

What is the current status of trial NCT02696603?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20,000 participants. The study started on 2015-03. Estimated completion is 2025-12-31.

What conditions does trial NCT02696603 study?

This clinical trial studies the following conditions: Parkinson Disease, Movement Disorders, Central Nervous System Diseases, Brain Diseases, Neurodegenerative Diseases.

What interventions are being tested in trial NCT02696603?

The interventions under investigation include: Participant self-assessment surveys (BEHAVIORAL), Phonation (BEHAVIORAL), Gait and balance (BEHAVIORAL), Memory (BEHAVIORAL), Dexterity (BEHAVIORAL).

Who is sponsoring clinical trial NCT02696603?

This trial is sponsored by Sage Bionetworks, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02696603 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Parkinson Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02696603's enrollment target sits among peer trials

20,000 3rd of 297 higher than 295 of 297 other Parkinson Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Parkinson Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00271180 · 20,000 participants

    Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • NCT00830557 · 20,000 participants

    Collecting Medical Information and Tissue Samples From Patients With Pancreatic Cancer or Other Pancreatic Disorders

  • NCT00900471 · 20,000 participants

    Collection and Storage of Tissue Samples From Patients Undergoing Surgery For Suspected Solid Tumors

  • NCT02735707 · 20,000 participants · Phase 3

    Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02696603, the US trial registry maintained by the National Library of Medicine. NCT02696603 (large enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.